Skip to content
10-Q

Quarterly Report

Celator Pharmaceuticals Inc

0001144204-16-100409

← back to feed
Filed
May 10, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 6, 2016 42.47M sh
Capex Q1 2016 · Mar 31, 2016 $3.3K
Capex Q1 2016 · Mar 31, 2015 $17.94K
Long Term Debt Q1 2016 · Mar 31, 2016 $12.84M
Long Term Debt Q1 2016 · Dec 31, 2015 $9.08M
Short Term Debt Q1 2016 · Mar 31, 2016 $436.69K
Short Term Debt Q1 2016 · Dec 31, 2015 $5.38M
Cash And Equivalents Q1 2016 · Mar 31, 2016 $67.54M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $23.25M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $32.9M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $32.41M
Stockholders Equity Q1 2016 · Mar 31, 2016 $52.63M
Stockholders Equity Q1 2016 · Dec 31, 2015 $6.53M
Current Liabilities Q1 2016 · Mar 31, 2016 $2.91M
Current Liabilities Q1 2016 · Dec 31, 2015 $8.58M
Total Liabilities Q1 2016 · Mar 31, 2016 $16.77M
Total Liabilities Q1 2016 · Dec 31, 2015 $18.69M
Current Assets Q1 2016 · Mar 31, 2016 $68.55M
Current Assets Q1 2016 · Dec 31, 2015 $24.31M
Total Assets Q1 2016 · Mar 31, 2016 $69.41M
Total Assets Q1 2016 · Dec 31, 2015 $25.22M
Sga Expense Q1 2016 · Mar 31, 2016 $2.47M
Sga Expense Q1 2016 · Mar 31, 2015 $1.76M
Rd Expense Q1 2016 · Mar 31, 2016 $2.69M
Rd Expense Q1 2016 · Mar 31, 2015 $2.71M
Net Income Q1 2016 · Mar 31, 2016 −$5.53M
Net Income Q1 2016 · Mar 31, 2015 −$4.71M
Operating Income Q1 2016 · Mar 31, 2016 −$5.06M
Operating Income Q1 2016 · Mar 31, 2015 −$4.38M